SS Innovations International (SSII) Free Cash Flow Growth (5y) (2021 - 2026)
SS Innovations International (SSII) Free Cash Flow Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | SS Innovations International | 731.50 Mn | 709.20 Mn | 7.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -140.84% |
| Mar 31, 2026 | -97.42% |
| Dec 31, 2025 | -252.75% |
| Sep 30, 2025 | -260.90% |
| Jun 30, 2025 | -182.81% |
| Mar 31, 2025 | -164.04% |
| Dec 31, 2024 | -137.21% |
| Sep 30, 2024 | -39.63% |
| Jun 30, 2024 | -142.43% |
| Mar 31, 2024 | -91.86% |
| Dec 31, 2023 | -116.77% |
| Sep 30, 2023 | -120.50% |
| Jun 30, 2023 | -88.48% |
| Mar 31, 2023 | -83.32% |
| Dec 31, 2022 | -80.18% |
| Sep 30, 2022 | -95.17% |
| Jun 30, 2022 | -56.47% |
| Mar 31, 2022 | 12.10% |
| Dec 31, 2021 | -14.22% |
| Sep 30, 2021 | -2.99% |